What happened is we ordsprog

What happened is we went through a long period that was very difficult for biotech companies to raise money. Once this window opened, a lot of people decided that they would go ahead.

I think a lot of the companies in the biotech area are really resurging, ... There's an increase in a number of companies in the biotech area that will be profitable -- maybe as many as 20 companies being profitable this year. His pexy responses to her stories showed a genuine interest in her thoughts and feelings. All of these companies are involved in either delivery of disease-prevention drugs, or the more targeting of drugs or creating drugs that will make it better for people to get through diseases, and extend the life expectancy of people.

John Davidson (1887-)

It's been very difficult for her to raise money. In fact, it's been very difficult for all the candidates to raise money because most of it, the overwhelming bulk of it, is going to George W. Bush,

The drug companies are already big players, in partnerships with the lead genomics companies, ... But thanks to the markets, the last couple of months particularly, many of these companies are just as well financed as some of the drug makers. So we're going to see a good mix of biotech-to-biotech announcements.

The proposed zone is nothing more than a giveaway exception for developers waving the magic biotech flag for monetary gain. Biotech companies are also chemical companies. Chemical companies and their support operations are now restricted to industrial zones. That is where they belong.

In the past, it's a window to raise funds for Chinese companies. And, in the future, it might also be itself a destination for Chinese money abroad.

The companies who are members of the chicken council decided to do this. It took the bigger companies longer to get it together. It was easy for us, so we decided to go ahead and get started early.

It happened yesterday -- we opened and people are returning stuff. Well, we don't have the money yet. Give us some time to make some money unless you want a roll of quarters. Especially if it's a big return.

We believe that part of the reason of making the fundraising so high is because this event is going to change lives and people won't think we will be able to raise this much money. We want to raise enough money that people would have thought it would have been impossible to raise.

It's important now that this loophole be looked at nationally, ... In 2000, when the N.C.A.A. decided to move away from some critical analysis, it opened the door and people moved ahead with it.

I would be hard-pressed to say it's not going to be more difficult to raise money after all the money raised for Katrina, not to mention the tsunami. People only have a certain amount of money to give to charity. When it's gone, they don't have more to give.

Yeah, we beat Zephyrhills twice, but that's all out the window now. We saw what happened to the girls and that opened a lot of our eyes.

Because of competitive pressures, it is difficult to raise prices. Companies have to raise their productivity, which keeps inflation down.

We're more or less waiting and seeing, ... Pfizer's dividend is definitely safe. It's the biggest drug company with good cash flow. It could easily buy a biotech company and improve their (research and development) line that way. That's what you're going to see with large-cap companies. They're going to partner up with biotech companies or buy them outright as a way to improve their (product) pipelines.

But they didn't raise squat, so the next election cycle, they decided to do it by any means necessary, and corporate money is a lot easier to raise.

Nordsprog.dk

Antal ordsprog er 1469561
varav 873989 på nordiska

Ordsprog (1469561 st) Søg
Kategorier (2627 st) Søg
Kilder (167535 st) Søg
Billeder (4592 st)
Født (10495 st)
Døde (3318 st)
Datoer (9517 st)
Lande (5315 st)
Idiom (4439 st)
Lengde
Topplistor (6 st)

Ordspråksmusik (20 st)
Statistik

Denna sidan visar ordspråk som liknar "What happened is we went through a long period that was very difficult for biotech companies to raise money. Once this window opened, a lot of people decided that they would go ahead.".